Biotech Values

[DewDiligence]

TRA-SCH 530348 addendum:

Although the initial push will be an indication as an adjunct to the antiplatelet SoC of Plavix + aspirin, SGP has not ruled out seeking to make TRA-SCH 530348 a replacement for Plavix (or whatever supersedes Plavix, e.g. prasugrel) once it is established as an adjunct. (Source: SGP CC)